PMID: 9169567Jun 1, 1997Paper

Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer

European Journal of Nuclear Medicine
S KosudaR L Wahl

Abstract

The purpose of this study was to assess the feasibility of imaging of bladder cancer with fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) scanning. We studied 12 patients with histologically proven bladder cancer who had undergone surgical procedures and/or radiotherapy. Retrograde irrigation of the urinary bladder with 1000-3710 ml saline was performed during nine of the studies. Dynamic and static PET images were obtained, and standardized uptake value images were reconstructed. FDG-PET scanning was true-positive in eight patients (66.7%), but false-negative in four (33.3%). Of 20 organs with tumor mass lesions confirmed pathologically or clinically, 16 (80%) were detected by FDG-PET scanning. FDG-PET scanning detected all of 17 distant metastatic lesions and two of three proven regional lymph node metastases. FDG-PET was also capable of differentiating viable recurrent bladder cancer from radiation-induced alterations in two patients. In conclusion, these preliminary data indicate the feasibility of FDG-PET imaging in patients with bladder cancer, although a major remaining pitfall is intense FDG accumulation in the urine.

References

Jan 1, 1990·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·S A ToorongianM R Kilbourn
Jan 1, 1988·Scandinavian Journal of Urology and Nephrology·M NurmiP Puntala
Dec 1, 1987·Cancer·K B NolopJ M Hughes
Jul 1, 1993·Journal of Computer Assisted Tomography·C K HohE Nitzsche

❮ Previous
Next ❯

Citations

Jun 16, 2004·Annals of Nuclear Medicine·Naoto WatanabeHikaru Seto
Nov 15, 2006·World Journal of Urology·Mansi A SaksenaMukesh G Harisinghani
Feb 9, 2013·Current Urology Reports·Nathan LawrentschukAndrew M Scott
Mar 17, 2011·Annals of Nuclear Medicine·Yuji AsanoKazushige Hayakawa
Dec 13, 2003·Urologic Oncology·Nicolette K JanzenArie S Belldegrun
Sep 29, 2000·Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T·S KunishimaH Yamagishi
Sep 13, 2005·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·S F Hain
Apr 12, 2013·BMC Medicine·Shaista Hafeez, Robert Huddart
Aug 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea B ApoloDean F Bajorin
Mar 31, 2010·The Indian Journal of Radiology & Imaging·S HarkiratMj Jacob
Oct 18, 2007·Radiology·Daniel J A MargolisSanjiv S Gambhir
Jul 13, 2005·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Naveen SubhasRichard L Wahl
Sep 1, 2005·European Journal of Nuclear Medicine and Molecular Imaging·O DrieskensL Mortelmans
Mar 22, 2006·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Jade J Wong-You-CheongIsabell A Sesterhenn
Apr 22, 2011·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·N BoujelbeneA Zouhair
Feb 22, 2011·Revista española de medicina nuclear·A M García VicenteA Soriano Castrejón
May 30, 2009·European Urology·Greet SwinnenPatrick Werbrouck
Jul 31, 2010·Advances in Urology·Ali A Al-Zahrani
Jul 11, 2006·The Urologic Clinics of North America·Timothy J BradfordKhaled S Hafez
Jun 26, 2003·BJU International·S F Hain, M N Maisey
Jan 3, 2013·International Journal of Urology : Official Journal of the Japanese Urological Association·Maryam Hitier-BerthaultJérôme Rigaud
Mar 29, 2012·International Journal of Urology : Official Journal of the Japanese Urological Association·Zhongyi YangYingjian Zhang
Apr 8, 2010·International Journal of Urology : Official Journal of the Japanese Urological Association·Norbert AvrilAnju Sahdev
Oct 20, 2004·Seminars in Nuclear Medicine·Heiko Schöder, Steven M Larson
Aug 6, 2000·Seminars in Nuclear Medicine·R Bar-ShalomM D Blaufox
Oct 19, 2004·Radiologic Clinics of North America·Rakesh KumarAbass Alavi
Dec 17, 2005·Seminars in Nuclear Medicine·Suman Jana, M Donald Blaufox
Mar 22, 2015·International Journal of Clinical Oncology·Seiji AsaiMasayoshi Yokoyama
Jun 24, 2015·PET Clinics·Kirsten Bouchelouche, Peter L Choyke
Jun 12, 2012·Seminars in Nuclear Medicine·Sze Ting LeeAndrew M Scott
Jul 20, 2016·Current Urology Reports·Cory M HugenSiamak Daneshmand
Aug 28, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Pierpaolo AlongiMassimo Midiri
Jun 4, 2016·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Mete UttamMandal Arup
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P G RoseF Miraldi
Mar 31, 2017·The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica·Lawrence O DierickxFrédéric Courbon
Jul 9, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Yan ZhaoNagara Tamaki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.